Pharma-Bio Serv (PBSV) Capital Leases (2010 - 2021)

Pharma-Bio Serv (PBSV) has reported Capital Leases for 11 consecutive years, with $52430.0 the latest figure, recorded in Q1 2021.

• For the quarter ending Q1 2021, Capital Leases fell 18.37% year-over-year to $52430.0; the trailing twelve-month figure through Jan 2021 stood at $52430.0 (down 18.37% YoY), and the FY2020 full-year result was $55439.0, down 17.35% from the prior year.
• Capital Leases slipped to $52430.0 in Q1 2021 per PBSV's latest filing, from $55439.0 in the prior quarter.
• Across five years, Capital Leases topped out at $72668.0 in Q2 2019 and bottomed at $20206.0 in Q2 2017.
• Historically, Capital Leases has averaged $53923.1 across 5 years, with a median of $56397.0 in 2018.
• The sharpest annual moves came in 2018 and 2019: Capital Leases jumped 162.12% in 2018, then decreased 24.61% in 2019.
• Over 5 years, Capital Leases stood at $59795.0 in 2017, then slipped by 23.03% to $46027.0 in 2018, then surged by 45.74% to $67079.0 in 2019, then retreated by 17.35% to $55439.0 in 2020, then decreased by 5.43% to $52430.0 in 2021.
• According to Business Quant data, Capital Leases over the past three periods registered $52430.0, $55439.0, and $58408.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.